Inactive Instrument

Other languages Swedish Orphan Biovitrum AB Xetra

Equities

B6E

SE0000872095

Other languages

Unlock all the news on all businesses: Never miss an investment opportunity again!

Swedish Orphan Biovitrum AB Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2024	16/07
Swedish Orphan Biovitrum AB Updates Earnings Guidance for the Year 2024	16/07
Sweden's Sobi Begins Rolling Application for Gout Treatment in US	02/07
Sobi Initiates Rolling Biologics License Application to FDA for SEL-212 for the Potential Treatment of Chronic Refractory Gout	02/07
Sobi Wins EU Approval for Hemophilia A Drug Altuvoct	19/06
European Commission Grants Sobi® Marketing Authorisation for Altuvoct? for Treatment of Haemophilia A	19/06
BerGenBio ASA Enter into A Clinical Trial Agreement with the Mays Cancer Center At the University of Texas Health Science Center At San Antonio and Swedish Orphan Biovitrum AB	28/05
Swedish Orphan Biovitrum AB Elects Zlatko Rihter as New Board Member	14/05
Sobi Finalizes Inaugural SEK3 Billion Bond Issue	08/05
Sobi Secures Additional EU Indication for Rare Blood Disorder Therapy	08/05
Sobi Wins EU Regulatory Panel's Positive Opinion for Hemophilia A Drug	26/04
Sobi Receives Positive CHMP Opinion Recommending Approval of efanesoctocog alfa for Once-Weekly Treatment of Haemophilia A	26/04
Sobi's SEK10 Billion Note Program Gets Regulatory Nod in Sweden	26/04
Avis d'analystes du jour : Hermès, Sanofi, STMicroelectronics, BNP Paribas, Pluxee, Valeo, Nestlé...	26/04
Swedish Orphan Biovitrum AB Reports Earnings Results for the First Quarter Ended March 31, 2024	25/04
Swedish Orphan Biovitrum AB Provides Earnings Guidance for 2024	25/04
AVIS D'ANALYSTES DU JOUR : Air Liquide, Carrefour, STMicro, Sartorius Stedim Biotech, Schneider, Soitec...	22/02
OPINIONES DE LOS ANALISTAS DEL DÍA : Inditex, Acciona Energia, Merlin Properties, Tod's, Euronext, ...	22/02
Sobi to Expand in South Korea via Rare Disease JV with Handok	13/02
Orexo, Swedish Orphan Biovitrum to Further Explore AmorphOX Combination	12/02

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Other languages Swedish Orphan Biovitrum AB Xetra

Equities

B6E

SE0000872095

Other languages

Filters